SCHEMBL2881872

SCHEMBL2881872

O=[C]CNC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL940070 0.90 EPHX1 (0.38)
SCHEMBL940071 0.90 EPHX1 (0.38)
SCHEMBL1051109 0.89
SCHEMBL7747239 0.89
SCHEMBL939875 0.87 KDM4E (0.48)
SCHEMBL7747093 0.87 KDM4E (0.48)
SCHEMBL7748472 0.87 KDM4E (0.48)
SCHEMBL8491948 0.85
SCHEMBL3638472 0.74
SCHEMBL20294037 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117794923-A Benzodioxane compound, and preparation method and application thereof 南京红云生物科技有限公司 2024-03-29 CN claimed
US-20230310428-A1 EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-10-05 US claimed
US-20230212147-A1 ALKENYL PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-07-06 US claimed
EP-4166553-A1 ALKENYL PYRIMIDINE COMPOUND, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-04-19 EP claimed
WO-2023011610-A1 BENZODIOXANE COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 南京红云生物科技有限公司 2023-02-09 WO claimed
CN-115697996-A Alkenyl pyrimidine compound, preparation method and application thereof 南京红云生物科技有限公司 2023-02-03 CN claimed
WO-2021238827-A1 EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF 南京红云生物科技有限公司 2021-12-02 WO claimed
CN-113717156-A EGFR inhibitor, preparation method and application thereof 南京红云生物科技有限公司 2021-11-30 CN claimed
US-20040077549-A1 Inhibitors of the E2F-1/cyclin interaction for cancer therapy BAIR KENNETH WALTER (US) 2004-04-22 US claimed
US-20040053849-A1 Inhibitors of the E2F-1/cyclin interaction for cancer therapy BAIR KENNETH WALTER (US) 2004-03-18 US claimed
EP-1345957-A2 INHIBITORS OF THE E2F-1/CYCLIN INTERACTION FOR CANCER THERAPY Novartis AG (CH) 2003-09-24 EP claimed
US-20020142966-A1 Inhibitors of the E2F-1/cyclin interaction for cancer therapy BAIR KENNETH WALTER (US) 2002-10-03 US claimed
WO-2002050102-A2 INHIBITORS OF THE E2F-1/CYCLIN INTERACTION FOR CANCER THERAPY NOVARTIS AG (CH) 2002-06-27 WO claimed
US-5834450-A 9- (substituted amino) -alpha-6-deoxy-5-oxy tetracycline derivatives, their preparation and their use as antibiotics PFIZER INC. (US) 1998-11-10 US claimed
EP-0745065-A1 9-(SUBSTITUTED AMINO)-ALPHA-6-DEOXY-5-OXY TETRACYCLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIBIOTICS PFIZER INC. (US) 1996-12-04 EP claimed
WO-1995022529-A1 9-(SUBSTITUTED AMINO)-ALPHA-6-DEOXY-5-OXY TETRACYCLINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTIBIOTICS PFIZER INC. (US) 1995-08-24 WO claimed
CN-117794923-A Benzodioxane compound, and preparation method and application thereof 南京红云生物科技有限公司 2024-03-29 CN disclosed
US-20230310428-A1 EGFR INHIBITOR AND PREPARATION METHOD AND USE THEREOF Hongyun Biotech Co., Ltd. (CN) 2023-10-05 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed
EP-0596406-A1 Imidazo (1,2-a) Pyridines as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-05-11 EP disclosed